Johnson Jason M, Castle John, Garrett-Engele Philip, Kan Zhengyan, Loerch Patrick M, Armour Christopher D, Santos Ralph, Schadt Eric E, Stoughton Roland, Shoemaker Daniel D
Rosetta Inpharmatics LLC, Merck & Co., Inc., 12040 115th Avenue N.E., Kirkland, WA 98034, USA.
Science. 2003 Dec 19;302(5653):2141-4. doi: 10.1126/science.1090100.
Alternative pre-messenger RNA (pre-mRNA) splicing plays important roles in development, physiology, and disease, and more than half of human genes are alternatively spliced. To understand the biological roles and regulation of alternative splicing across different tissues and stages of development, systematic methods are needed. Here, we demonstrate the use of microarrays to monitor splicing at every exon-exon junction in more than 10,000 multi-exon human genes in 52 tissues and cell lines. These genome-wide data provide experimental evidence and tissue distributions for thousands of known and novel alternative splicing events. Adding to previous studies, the results indicate that at least 74% of human multi-exon genes are alternatively spliced.
可变前体信使核糖核酸(pre-mRNA)剪接在发育、生理和疾病过程中发挥着重要作用,超过半数的人类基因存在可变剪接。为了解不同组织和发育阶段可变剪接的生物学作用及调控机制,需要系统的方法。在此,我们展示了利用微阵列监测52种组织和细胞系中10000多个多外显子人类基因的每个外显子-外显子连接处的剪接情况。这些全基因组数据为数千种已知和新型可变剪接事件提供了实验证据及组织分布情况。与先前的研究结果相加,结果表明至少74%的人类多外显子基因存在可变剪接。